Elegir un idioma

Inicio
Nosotros
Cáncer Renal
Casos clínicos
Artículos
Videos
Noticias
Miembros
- Ingresar
- Cuenta
- Salir

Inicio
Nosotros
Cáncer Renal
Casos clínicos
Artículos
Videos
Noticias
Miembros
- Ingresar
- Cuenta
- Salir

Casos clínicos

marzo 25, 2019 In Casos clínicos

Caso clínico HA1

You don’t have permission to view the content

Facebook
Twitter
Google+
LinkedIn

Search for:

Entradas recientes

Pathologic response and surgical outcomes in patients undergoing nephrectomy following receipt of immune checkpoint inhibitors for renal cell carcinoma
The Evaluation of Response to Immunotherapy in Metastatic Renal Cell Carcinoma: Open Challenges in the Clinical Practice
Predictors of Survival Outcomes in Non-Metastatic Renal Cell Carcinoma in Latin America and Spain: A Multicentric Analysis
Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

©2019 LARCG – Todos los derechos reservados

Contacto

larcgorg@gmail.com

Seguinos

Youtube | Twitter

Asociados

IKCC Internacional Kidney Cancer Coalition
NIH National Cancer Institute
Latín American Collaborative Oncology Group

Sponsor

A. C. Camargo Cancer Center

Diseño web: /JMB

Login
Register

Remember me

Lost Your password?

You don't have permission to register